NCT07392515 Cognitive and Physical Recovery After Hip Fracture in Frail Patients Using Digital Rehabilitation Technology
| NCT ID | NCT07392515 |
| Status | Recruiting |
| Phase | — |
| Sponsor | C.O.T. Cure Ortopediche Traumatologiche S.p.A. |
| Condition | Fracture Femur |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-02-09 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-02-09 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate whether integrating a technology-based rehabilitation approach with conventional therapies in the rehabilitation of patients with proximal femoral fracture may be advantageous compared with conventional therapy alone. Specifically, the objective is to assess whether the addition of technology-assisted rehabilitation can improve cognitive function, in addition to motor function and overall abilities, compared with conventional rehabilitation alone. Furthermore, the study intends to explore the feasibility of implementing technology-assisted rehabilitation as a stable and routine component of everyday clinical practice, also considering the perspective of healthcare professionals.
Eligibility Criteria
Inclusion Criteria: * Age between 65 and 89 years * Patients who have undergone one of the following surgical treatments specifically for proximal femur fracture including Total hip arthroplasty (total hip replacement), Partial hip arthroplasty (hemiarthroplasty), Intramedullary nailing * Time since surgery not exceeding 15 days * Clinical stability * Patients admitted to the rehabilitation wards of the centers involved in the study and therefore eligible for rehabilitative therapy. Exclusion Criteria: * Age \> 90 years * Age \< 65 years * Refusal to sign the informed consent form * Behavioral or cognitive disorders limiting compliance with the rehabilitative treatment * Presence of mechanical instability of the implanted surgical device * Clinical instability (e.g., sepsis, severe anemia, cardiorespiratory failure) or pre-existing comorbidities affecting ambulation (neurological diseases or chronic pre-existing disabilities) * Concomitant presence of other fractures that prevent the possibility of carrying out a rehabilitative treatment * Severe visual impairments not correctable with lenses that prevent the patient from performing the treatment using digital tools * Pre-existing motor disability prior to the femur fracture due to other systemic diseases (e.g., advanced-stage neurodegenerative diseases, severe heart failure) * Conditions contraindicating the use of sensors (pacemaker, epilepsy, skin lesions, open wounds, and severe allergies in areas of contact with the devices).
Frequently Asked Questions
Who can join the NCT07392515 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 89 Years, studying Fracture Femur. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07392515 currently recruiting?
Yes, NCT07392515 is actively recruiting participants. Visit ClinicalTrials.gov or contact C.O.T. Cure Ortopediche Traumatologiche S.p.A. to inquire about joining.
Where is the NCT07392515 trial being conducted?
This trial is being conducted at Messina, Italy, Roma, Italy.
Who is sponsoring the NCT07392515 clinical trial?
NCT07392515 is sponsored by C.O.T. Cure Ortopediche Traumatologiche S.p.A.. The trial plans to enroll 30 participants.